Cargando…

Targeting Head and Neck Cancer by Vaccination

Head and neck cancer (HNC) is a heterogeneous group of squamous cell cancers that affect the oral cavity, pharynx, and larynx. Worldwide, it is the sixth most common cancer but in parts of Southern and South-East Asia, HNC is one of the most common cancers. A significant proportion of HNC is driven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chuan, Dickie, James, Sutavani, Ruhcha V., Pointer, Catherine, Thomas, Gareth J., Savelyeva, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924779/ https://www.ncbi.nlm.nih.gov/pubmed/29740440 http://dx.doi.org/10.3389/fimmu.2018.00830

Ejemplares similares

DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor
por: Wang, Chuan, et al.
Publicado: (2021)

Differential control of Toll-like receptor 4–induced interleukin-10 induction in macrophages and B cells reveals a role for p90 ribosomal S6 kinases
por: Sutavani, Ruhcha V., et al.
Publicado: (2018)

Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction
por: Hayakawa, Morisada, et al.
Publicado: (2017)

Immune Checkpoint Inhibition in Head and Neck Cancer
por: Forster, Martin David, et al.
Publicado: (2018)

The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment
por: Zhang, Ye, et al.
Publicado: (2023)

ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
por: Mellone, Massimiliano, et al.
Publicado: (2022)

Regulation of epigenetic modifications in the head and neck tumour microenvironment
por: Liu, Huimin, et al.
Publicado: (2022)

The Double-Edged Sword—How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer
por: Wang, Hao-fan, et al.
Publicado: (2019)

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma
por: Ciulean, Ioana Sonya, et al.
Publicado: (2023)

On the Road to Immunotherapy—Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies
por: Ward, Frank J., et al.
Publicado: (2018)

Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer
por: Hu, Chunmei, et al.
Publicado: (2023)

The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer
por: Qiao, Xin-wei, et al.
Publicado: (2020)

Risk of head and neck cancer in relation to blood inflammatory biomarkers in the Swedish AMORIS cohort
por: Yang, Yanping, et al.
Publicado: (2023)

Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma
por: Jin, Won Jong, et al.
Publicado: (2020)

Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects
por: Özcan-Wahlbrink, Mine, et al.
Publicado: (2019)

Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers
por: Raza, Afsheen, et al.
Publicado: (2023)

The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma
por: Liao, Peng, et al.
Publicado: (2019)

Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma
por: Xu, Qing-Qing, et al.
Publicado: (2021)

Impaired intratumoral natural killer cell function in head and neck carcinoma
por: Mele, Dalila, et al.
Publicado: (2022)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

TNF Patterns and Tumor Microenvironment Characterization in Head and Neck Squamous Cell Carcinoma
por: Long, Qian, et al.
Publicado: (2021)

Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
por: Merhi, Maysaloun, et al.
Publicado: (2018)

Association Between Vitamin D Exposure and Head and Neck Cancer: A Systematic Review With Meta-Analysis
por: Pu, Yuting, et al.
Publicado: (2021)

Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer
por: Takami, Mariko, et al.
Publicado: (2018)

Personalized cancer vaccination in head and neck cancer
por: Shibata, Hirofumi, et al.
Publicado: (2021)

The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication
por: Dou, Shengjin, et al.
Publicado: (2021)

Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis
por: Botticelli, Andrea, et al.
Publicado: (2021)

Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma
por: Zou, Wen-Qing, et al.
Publicado: (2022)

Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
por: Jiang, Siqing, et al.
Publicado: (2022)

A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer
por: Mourtada, Jana, et al.
Publicado: (2023)

Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer
por: McCann, Katy, et al.
Publicado: (2022)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing
por: Xiao, Mintao, et al.
Publicado: (2022)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
por: Röhl, Louisa, et al.
Publicado: (2023)

Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer
por: Clubb, James H. A., et al.
Publicado: (2022)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Xinwen, et al.
Publicado: (2021)

DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Fu, Ling-ling, et al.
Publicado: (2022)

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma
por: Xu, Qing-Qing, et al.
Publicado: (2023)

Head and neck dermatitis is exacerbated by Malassezia furfur colonization, skin barrier disruption, and immune dysregulation
por: Chu, Howard, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l99qcmt09klj941hog75b7oqpr